To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: DG DISPATCH - AAN: Rapid infusion valproate sodium safe and effective for epilepsy URL: http://www.pslgroup.com/dg/1CF07A.htm Doctor's Guide May 1, 2000
By Richard Robinson Special to DG News
SAN DIEGO, CA -- May 1, 2000 -- Rapid infusion is a safe alternative to slow infusion for epilepsy patients needing intravenous valproate sodium, clinical research shows.
The currently approved method of administration of valproate sodium (Depacon) calls for slow infusion, with one-fourth of the daily dose every six hours infused over one hour at each administration. Rapid administration, however, has proven safe in animal experiments noted R. Eugene Ramsay, MD, of the International Center for Epilepsy, in Miami, FL.
Dr. Ramsay and colleagues tested the safety of rapid infusion among 40 patients with partial seizures who required valproate sodium treatment, either for seizure prophylaxis, low serum levels in ongoing treatment, or as first-line intervention for acute seizure treatment. The patients were randomized to receive either 1.5 or 3.0 mg/kg/min of valproate sodium, to a target concentration of 15 mg/kg.
Dr. Ramsay presented the findings of the study at the 52nd Annual Meeting of the American Academy of Neurology, held in San Diego, CA, April 30, 2000.
No changes were seen in vital signs, EKG, serum chemistry, or complete blood count in either group, and no adverse effects at injection site were seen either immediately or 48 hours after infusion. Subjective side effects were seen in 35 percent of patients -- including dizziness, drowsiness, headache, and upset stomach -- but with no significant difference in occurrence between groups.
"We now have data to show that rapid infusion is safe," Dr. Ramsay said, and noted he is continuing to explore whether even more rapid infusion may be even more efficacious.
The study, "Safety of high-dose rapid infusion of intravenous valproate sodium," was supported by Abbott Laboratories.
Related Links: valproate sodium (Depacon) and Abbott Laboratories. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.